Ovarian Cancer

SEP 8, 2026 · OBSERVATIONAL STUDY

Tissue Acquisition and Genomics Analysis of Breast Cancer and Other Gynecologic Malignancies

ClinicalTrials.gov

This is a prospective observational tissue repository and biobank study with no results reported; it documents planned enrollment and collection procedures for future genomic research.

SEP 4, 2026 · PHASE 1 TRIAL

A Study to Test the Safety, Tolerability and Effect of ZI-MA4-1 for Patients With Locally Advanced or Metastatic Solid Malignancies

ClinicalTrials.gov

First-in-human Phase 1 dose-escalation trial of a novel allogeneic cell therapy with no results yet reported; registration only.

AUG 18, 2026 · PHASE 1 TRIAL

First-in-Human Study of ATX-295, an Oral Inhibitor of KIF18A, in Patients With Advanced or Metastatic Solid Tumors, Including Ovarian Cancer

ClinicalTrials.gov

First-in-human Phase 1 dose-escalation study with no results posted; designed to establish safety, tolerability, and dose recommendations rather than efficacy.

AUG 17, 2026 · PHASE 1/2 TRIAL

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

ClinicalTrials.gov

This is a first-in-human Phase 1/2 study still in recruitment with no results posted; it aims to establish safety, pharmacokinetics, and preliminary efficacy of a novel antibody-drug conjugate.

AUG 13, 2026 · OBSERVATIONAL STUDY

Removal of the Ovaries/Fallopian Tubes and CA-125 Screening to Reduce the Risk of Ovarian Cancer in Women at Increased Genetic Risk

ClinicalTrials.gov

This is a completed observational registry study with analysis finished but no results reported in this record; it describes planned enrollment and outcomes rather than findings, making it preliminary evidence until peer-reviewed results are published.

AUG 13, 2026 · PHASE 2 TRIAL

Administration of Autologous T-Cells Genetically Engineered to Express T-Cell Receptors Reactive Against Neoantigens in People With Metastatic Cancer

ClinicalTrials.gov

This is a Phase 2 interventional trial registration with no results yet posted; it describes planned enrollment and study design only, making it an early-stage assessment of a novel cell therapy approach.

AUG 11, 2026 · PHASE 1/2 TRIAL

XNW27011 Study of Advanced Solid Tumor Subjects Who Failed Standard Therapies.

ClinicalTrials.gov

This is a first-in-human Phase 1/2 trial registration with no results reported; the study is active but not yet recruiting and endpoints are not yet measured.

AUG 7, 2026 · PHASE 1/2 TRIAL

A Study of LG00313112 in Participants With Advanced Solid Malignancies Harboring a TP53 Y220C Mutation

ClinicalTrials.gov

This is a clinical trial registry record for a planned first-in-human Phase 1/2 study with no results posted; enrollment has not yet begun.